Meet our team of highly skilled and dedicated individuals
Maxim Rossmann, Ph.D. Biochemistry
CEO, co-founderOver 15 years experience in molecular biology, cancer biology, biochemical and biophysical techniques for development of molecular therapies.
Irina Soltamova Solovyev, M.Sc. Economics
CFO, co-founderOver 25 years experience in financial and business consulting and auditing.Strong expertise in Due Diligence, International Financial Reporting Standards, Financial Modelling, International Taxation for the large producing, insurance and financial corporations.
Dmitry Soloviev, Ph.D. Chemistry, MRSC
Clinical lead, co-founderOver 25 years experience in development of diagnostic radiopharmaceuticals for Positron Emission Tomography. Expert in GMP production of cyclotron-produced radiopharmaceuticals at IAEA, Vienna.
Rebecca Stacey, B.Sc. Biochemistry
Laboratory scientistRebecca graduated from Liverpool John Moores University with a 2:2 Bsc in Biochemistry. She has a vast amount of experience within the food industry, microbiology and ELISA machinery. Rebecca has full training in X-Ray fluorescence spectroscopy, sample preparation and XRF data analysis.
Simon Roff, HNC Engineering
Over 30 years experience in innovative medical device design and manufacture, new product support, introduction,
validation and testing, risk management of products, research and development of new technology for IP, Health and Safety,
COSHH implementation, quality management and GMP.
Prof. Mark Emberton
Dean of UCL Faculty of Medical Sciences and Professor of Interventional Oncology at UCLMark Emberton’s principal interests lie in trying to improve diagnostic and therapeutic pathways for men with prostate cancer, principally through the use of novel diagnostic, imaging techniques and minimally-invasive treatments
Prof. Lutz Schomburg Ph.D. Biochemistry
Scientific Adviser, co-founderProf. for Experimental Endocrinology, Vice Director Institute for Experimental Endocrinology, Charité – Universitätsmedizin Berlin. Over 20 years experience in endocrinology, development and validation of novel In Vitro Diagnostic Assays.
Sir Michael Snyder
DSc, FRSA, FCA, FInstD, MSI Honorary Head of Advisory BoardConsultant and former Senior Partner of top-20 Chartered Accountants Kingston Smith LLP. Among numerous assignments he was Chairman of the Association of Practicing Accountants, served as Co-Chairman of the Government’s Professional Business Services Council and lead the City Corporation as Policy and Resources Chairman. He is currently a Non-Executive Director of Metro Bank.
Prof. Vladimir Zaichick, Ph.D. Physics, FRSC
Scientific AdviserOver 50 years experience in medicinal physics and diagnostic method development. Prof. Zaichick’s long and fruitful scientific career was dedicated to studying elemental and chemical composition of human organs. He pioneered development of numerous novel in vivo and in vitro cancer diagnostic tests.